- Home
- ROIV vs CFLT Comparison
ROIV vs CFLT Comparison
Compare ROIV & CFLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- CFLT
- Stock Information
- Founded
- ROIV 2014
- CFLT 2014
- Country
- ROIV United Kingdom
- CFLT United States
- Employees
- ROIV N/A
- CFLT N/A
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- CFLT EDP Services
- Sector
- ROIV Health Care
- CFLT Technology
- Exchange
- ROIV Nasdaq
- CFLT Nasdaq
- Market Cap
- ROIV 8.4B
- CFLT 8.1B
- IPO Year
- ROIV N/A
- CFLT 2021
- Fundamental
- Price
- ROIV $10.87
- CFLT $21.96
- Analyst Decision
- ROIV Buy
- CFLT Buy
- Analyst Count
- ROIV 4
- CFLT 30
- Target Price
- ROIV $17.50
- CFLT $31.00
- AVG Volume (30 Days)
- ROIV 5.3M
- CFLT 7.4M
- Earning Date
- ROIV 05-29-2025
- CFLT 04-30-2025
- Dividend Yield
- ROIV N/A
- CFLT N/A
- EPS Growth
- ROIV N/A
- CFLT N/A
- EPS
- ROIV N/A
- CFLT N/A
- Revenue
- ROIV $122,585,000.00
- CFLT $1,017,525,000.00
- Revenue This Year
- ROIV N/A
- CFLT $21.52
- Revenue Next Year
- ROIV N/A
- CFLT $18.45
- P/E Ratio
- ROIV N/A
- CFLT N/A
- Revenue Growth
- ROIV 140.04
- CFLT 24.11
- 52 Week Low
- ROIV $8.73
- CFLT $17.79
- 52 Week High
- ROIV $13.06
- CFLT $37.90
- Technical
- Relative Strength Index (RSI)
- ROIV 51.00
- CFLT 47.59
- Support Level
- ROIV $10.58
- CFLT $20.95
- Resistance Level
- ROIV $11.07
- CFLT $22.05
- Average True Range (ATR)
- ROIV 0.30
- CFLT 0.79
- MACD
- ROIV -0.04
- CFLT 0.10
- Stochastic Oscillator
- ROIV 30.21
- CFLT 55.93
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About CFLT Confluent Inc.
Confluent Inc provides a data streaming platform that enables customers to connect their applications, systems, and data layers and can be deployed as a fully managed cloud-native software-as-a-service (SaaS) offering. Its products include Confluent Cloud, a self-managed software offering, Confluent Platform, a managed service offering where the raw data resides inside a customer's cloud environment, and WarpStream, among others. Confluent also offers professional services and education services. The company generates revenue from the sale of subscriptions and services. Geographically, it generates a majority of its revenue from its business in the United States and the rest from International markets.